Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Myelogenous Leukemia, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00003003
What this trial is testing

Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Dartmouth-Hitchcock Medical Center 29
Early research (Phase 1)Study completedNCT01380756
What this trial is testing

Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia

Who this might be right for
CancerHematologic MalignanciesLeukemia+1 more
Amgen 35
Large-scale testing (Phase 3)Study completedNCT00003883
What this trial is testing

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 578
Not applicableStudy completedNCT05335369
What this trial is testing

A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists

Who this might be right for
Acute Myeloid Leukemia
University of Rochester 161
Not applicableUnknownNCT06188182
What this trial is testing

D-index as a Predictor of Complication of Treatment of Patients With Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Assiut University 60
Not applicableActive Not RecruitingNCT05424562
What this trial is testing

Assess Change in Disease State in Adult Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy Receiving Oral Venetoclax Tablets in Canada

Who this might be right for
Acute Myeloid Leukemia
AbbVie 210
Early research (Phase 1)Study completedNCT03081780
What this trial is testing

Open Label NK Cell Infusion (FATE-NK100) With Subq IL-2 in Adults With AML

Who this might be right for
Refractory Acute Myelogenous LeukemiaRelapsed Acute Myelogenous Leukemia
Masonic Cancer Center, University of Minnesota 6
Early research (Phase 1)Study completedNCT00002693
What this trial is testing

Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia

Who this might be right for
LeukemiaNeutropenia
Mayo Clinic
Early research (Phase 1)Active Not RecruitingNCT01861314
What this trial is testing

Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Post Cytotoxic TherapyRecurrent Adult Acute Myeloid Leukemia+1 more
National Cancer Institute (NCI) 15
Not applicableLooking for participantsNCT05350748
What this trial is testing

Comprehensive Molecular and Clinical Evaluation of Pediatric and Adult MDS

Who this might be right for
Myelodysplastic Syndromes
National Cancer Institute (NCI) 1,100
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Not applicableApproved For MarketingNCT01869803
What this trial is testing

Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Promyelocytic Leukemia

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+7 more
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)Study completedNCT01093586
What this trial is testing

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+73 more
Case Comprehensive Cancer Center 14
Testing effectiveness (Phase 2)WithdrawnNCT03932318
What this trial is testing

Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients

Who this might be right for
Acute Myeloid LeukemiaRelapsed Adult AML
Actinium Pharmaceuticals
Early research (Phase 1)Study completedNCT01634217
What this trial is testing

Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+5 more
Masonic Cancer Center, University of Minnesota 16
Not applicableLooking for participantsNCT01137825
What this trial is testing

Registry of Older Patients With Cancer

Who this might be right for
Chronic Myeloproliferative DisordersCognitive/Functional EffectsLeukemia+6 more
UNC Lineberger Comprehensive Cancer Center 3,000
Testing effectiveness (Phase 2)Ended earlyNCT02349178
What this trial is testing

Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT

Who this might be right for
Leukemia, Acute LymphoblasticAcute Myeloid Leukemia
Medical College of Wisconsin 6
Large-scale testing (Phase 3)Looking for participantsNCT04628026
What this trial is testing

Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2

Who this might be right for
Acute Myeloid Leukemia
University of Ulm 650
Large-scale testing (Phase 3)Study completedNCT00438958
What this trial is testing

Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+3 more
The Canadian Blood and Marrow Transplant Group 230
Large-scale testing (Phase 3)Study completedNCT00112554
What this trial is testing

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

Who this might be right for
Leukemia
Vion Pharmaceuticals 420
Next Page